Literature DB >> 8977613

Diffuse panbronchiolitis in an Asian immigrant.

O Brugiere1, B Milleron, M Antoine, M F Carette, C Philippe, C Mayaud.   

Abstract

Diffuse panbronchiolitis (DPB) is a disease with chronic inflammation exclusively located in the region of the respiratory bronchiole. It is largely restricted geographically to the Far East, and cases in Western countries are exceptional, even among Asian immigrants. A patient of Asian origin with DPB who had been living in France for 10 years is described. Only re-examination of the initial open lung biopsy specimen after an eight year period allowed this rare disease to be diagnosed correctly. The known efficacy of low dose erythromycin in DPB was again confirmed after failure of long term high dose corticosteroid therapy administered before an accurate diagnosis had been made.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977613      PMCID: PMC472677          DOI: 10.1136/thx.51.10.1065

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  Diffuse panbronchiolitis in North America. Report of three cases and review of the literature.

Authors:  P Randhawa; M H Hoagland; S A Yousem
Journal:  Am J Surg Pathol       Date:  1991-01       Impact factor: 6.394

2.  [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis].

Authors:  S Kudoh; T Uetake; K Hagiwara; M Hirayama; L H Hus; H Kimura; Y Sugiyama
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1987-06

3.  Diffuse panbronchiolitis: evaluation with high-resolution CT.

Authors:  M Akira; F Kitatani; Y S Lee; N Kita; S Yamamoto; T Higashihara; S Morimoto; J Ikezoe; T Kozuka
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

4.  Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations.

Authors:  M Iwata; T V Colby; M Kitaichi
Journal:  Hum Pathol       Date:  1994-04       Impact factor: 3.466

5.  Diffuse panbronchiolitis: efficacy of low-dose erythromycin.

Authors:  J Tredaniel; G Zalcman; F Gerber; M F D'Agay; F Capron; J Frija; A Hirsch
Journal:  Respir Med       Date:  1993-04       Impact factor: 3.415

6.  Diffuse panbronchiolitis. A disease of the transitional zone of the lung.

Authors:  H Homma; A Yamanaka; S Tanimoto; M Tamura; Y Chijimatsu; S Kira; T Izumi
Journal:  Chest       Date:  1983-01       Impact factor: 9.410

7.  Analysis of HLA antigens in patients with diffuse panbronchiolitis.

Authors:  Y Sugiyama; S Kudoh; H Maeda; H Suzaki; F Takaku
Journal:  Am Rev Respir Dis       Date:  1990-06

8.  A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.

Authors:  J Kadota; O Sakito; S Kohno; H Sawa; H Mukae; H Oda; K Kawakami; K Fukushima; K Hiratani; K Hara
Journal:  Am Rev Respir Dis       Date:  1993-01

9.  Recurrence of diffuse panbronchiolitis after lung transplantation.

Authors:  M A Baz; P S Kussin; P Van Trigt; R D Davis; V L Roggli; V F Tapson
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

  9 in total
  10 in total

1.  Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis.

Authors:  H Satoh; H Ishikawa; Y T Yamashita; M Ohtsuka; K Sekizawa
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

Review 2.  Macrolides in the respiratory tract in cystic fibrosis.

Authors:  Adam Jaffé; Mark Rosenthal
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 3.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 4.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.

Authors:  Masaaki Sumi; Hiroaki Satoh; Katsunori Kagohashi; Hiroichi Ishikawa; Kiyohisa Sekizawa
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 7.  Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

Authors:  Paul King
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Clinical profiles of Chinese patients with diffuse panbronchiolitis.

Authors:  K W Tsang; C G Ooi; M S Ip; W K Lam; H Ngan; E Y Chan; B Hawkins; C S Ho; R Amitani; E Tanaka; H Itoh
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

9.  Diffuse panbronchiolitis: not just an Asian disease: Australian case series and review of the literature.

Authors:  Mp Anthony; S Singham; B Soans; G Tyler
Journal:  Biomed Imaging Interv J       Date:  2009-10-01

10.  Diffuse panbronchiolitis, a potentially misdiagnosed sinopulmonary syndrome.

Authors:  Atilla G Atici; Serhat Findik; Bilal Sengul; Levent Yildiz; Oguz Uzun; Levent Erkan
Journal:  Ann Saudi Med       Date:  2005 Nov-Dec       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.